(Q42551396)

2 November 2017

0 references

Interferon-ribavirin combination therapy for chronic hepatitis C. (English)

1 reference

2 November 2017

1 reference

1 reference

8

1 reference

2 November 2017

S W Schalm

1

1 reference

2 November 2017

J T Brouwer

2

1 reference

2 November 2017

L Chemello

3

1 reference

2 November 2017

A Alberti

4

1 reference

2 November 2017

A Bellobuono

5

1 reference

2 November 2017

G Ideo

6

1 reference

2 November 2017

R Schwartz

7

1 reference

2 November 2017

1 December 1996

1 reference

Digestive Diseases and Sciences

2 November 2017

1 reference

2 November 2017

41

1 reference

2 November 2017

12 Suppl

1 reference

2 November 2017

131S-134S

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02087889

2 November 2017

0 references

cites work

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02087889

Ribavirin treatment for chronic hepatitis C

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9011471

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9011471

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF02087889

1 reference

release_vcxscsmndvfkxkdzrc6tgxbk6e

2 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vcxscsmndvfkxkdzrc6tgxbk6e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference